Izotropic Corporation (OTCMKTS:IZOZF – Free Report) – Equities researchers at Zacks Research lowered their Q3 2027 EPS estimates for Izotropic in a research note issued to investors on Tuesday, August 25th. Zacks Research analyst B. Sorensen now expects that the company will earn $0.00 per share for the quarter, down from their previous estimate of $0.02. The consensus estimate for Izotropic’s current full-year earnings is $0.03 per share. Zacks Research also issued estimates for Izotropic’s Q4 2027 earnings at $0.01 EPS and FY2028 earnings at $0.08 EPS.
Izotropic Stock Up 1.3%
Shares of OTCMKTS IZOZF opened at $0.17 on Thursday. The firm’s 50 day simple moving average is $0.18 and its 200-day simple moving average is $0.18. Izotropic has a 12 month low of $0.12 and a 12 month high of $0.37.
About Izotropic
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
See Also
- Five stocks we like better than Izotropic
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
